These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
469 related items for PubMed ID: 30903869
1. Inflammatory chemokine profiles and their correlations with effector CD4 T cell and regulatory cell subpopulations in cutaneous lupus erythematosus. Méndez-Flores S, Hernández-Molina G, Azamar-Llamas D, Zúñiga J, Romero-Díaz J, Furuzawa-Carballeda J. Cytokine; 2019 Jul; 119():95-112. PubMed ID: 30903869 [Abstract] [Full Text] [Related]
2. Cytokines and Effector/Regulatory Cells Characterization in the Physiopathology of Cutaneous Lupus Erythematous: A Cross-Sectional Study. Méndez-Flores S, Hernández-Molina G, Enríquez AB, Faz-Muñoz D, Esquivel Y, Pacheco-Molina C, Furuzawa-Carballeda J. Mediators Inflamm; 2016 Jul; 2016():7074829. PubMed ID: 27041826 [Abstract] [Full Text] [Related]
4. Invariant natural killer T cells are enriched at the site of cutaneous inflammation in lupus erythematosus. Hofmann SC, Bosma A, Bruckner-Tuderman L, Vukmanovic-Stejic M, Jury EC, Isenberg DA, Mauri C. J Dermatol Sci; 2013 Jul; 71(1):22-8. PubMed ID: 23664188 [Abstract] [Full Text] [Related]
5. Skin CD4+ Trm cells distinguish acute cutaneous lupus erythematosus from localized discoid lupus erythematosus/subacute cutaneous lupus erythematosus and other skin diseases. Zhao Z, Zhu H, Li Q, Liao W, Chen K, Yang M, Long D, He Z, Zhao M, Wu H, Lu Q. J Autoimmun; 2022 Apr; 128():102811. PubMed ID: 35278775 [Abstract] [Full Text] [Related]
6. Characterization of autoantibodies and cytokines related to cutaneous lupus erythematosus. Hu FQ, Zhang YP, Yin J, Tang ZQ, Han YF, Shi ZR, Tan GZ, Wang L. Lupus; 2021 Feb; 30(2):315-319. PubMed ID: 33086919 [Abstract] [Full Text] [Related]
7. MicroRNA Expression in Cutaneous Lupus: A New Window to Understand Its Pathogenesis. Méndez-Flores S, Furuzawa-Carballeda J, Hernández-Molina G, Ramírez-Martinez G, Regino-Zamarripa NE, Ortiz-Quintero B, Jiménez-Alvarez L, Cruz-Lagunas A, Zúñiga J. Mediators Inflamm; 2019 Feb; 2019():5049245. PubMed ID: 32082077 [Abstract] [Full Text] [Related]
8. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus. Cai Z, Wong CK, Kam NW, Dong J, Jiao D, Chu M, Lam CW, Tam LS. Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926 [Abstract] [Full Text] [Related]
9. Clinical, histologic, and immunofluorescent distinctions between subacute cutaneous lupus erythematosus and discoid lupus erythematosus. David-Bajar KM, Bennion SD, DeSpain JD, Golitz LE, Lee LA. J Invest Dermatol; 1992 Sep; 99(3):251-7. PubMed ID: 1512459 [Abstract] [Full Text] [Related]
10. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship. Wouters CH, Diegenant C, Ceuppens JL, Degreef H, Stevens EA. Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365 [Abstract] [Full Text] [Related]
11. The expression pattern of interferon-inducible proteins reflects the characteristic histological distribution of infiltrating immune cells in different cutaneous lupus erythematosus subsets. Wenzel J, Zahn S, Mikus S, Wiechert A, Bieber T, Tüting T. Br J Dermatol; 2007 Oct; 157(4):752-7. PubMed ID: 17714558 [Abstract] [Full Text] [Related]
12. Analysis of FOXP3+ regulatory T cell subpopulations in peripheral blood and tissue of patients with systemic lupus erythematosus. Schmidt A, Rieger CC, Venigalla RK, Éliás S, Max R, Lorenz HM, Gröne HJ, Krammer PH, Kuhn A. Immunol Res; 2017 Apr; 65(2):551-563. PubMed ID: 28224362 [Abstract] [Full Text] [Related]
13. BAFFR expression in circulating T follicular helper (CD4+CXCR5+PD-1+) and T peripheral helper (CD4+CXCR5-PD-1+) cells in systemic lupus erythematosus. Sagrero-Fabela N, Ortíz-Lazareno PC, Salazar-Camarena DC, Cruz A, Cerpa-Cruz S, Muñoz-Valle JF, Marín-Rosales M, Alvarez-Gómez JA, Palafox-Sánchez CA. Lupus; 2023 Aug; 32(9):1093-1104. PubMed ID: 37460408 [Abstract] [Full Text] [Related]
14. The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score. Braunstein I, Klein R, Okawa J, Werth VP. Br J Dermatol; 2012 May; 166(5):971-5. PubMed ID: 22242767 [Abstract] [Full Text] [Related]
15. Increased CD4+CD25-Foxp3+ T cells in Chinese systemic lupus erythematosus: correlate with disease activity and organ involvement. Yin ZJ, Ju BM, Zhu L, Hu N, Luo J, He M, Feng XY, Lv XH, Pu D, He L. Lupus; 2018 Nov; 27(13):2057-2068. PubMed ID: 30336752 [Abstract] [Full Text] [Related]
16. Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus. Wenzel J, Wörenkämper E, Freutel S, Henze S, Haller O, Bieber T, Tüting T. J Pathol; 2005 Mar; 205(4):435-42. PubMed ID: 15685590 [Abstract] [Full Text] [Related]
17. The CD40/CD40 ligand system in the skin of patients with subacute cutaneous lupus erythematosus. Caproni M, Torchia D, Antiga E, Giomi B, Mercuri M, Volpi W, Fabbri P. J Rheumatol; 2007 Dec; 34(12):2412-6. PubMed ID: 18050371 [Abstract] [Full Text] [Related]
18. Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients. Vera-Recabarren MA, García-Carrasco M, Ramos-Casals M, Herrero C. Br J Dermatol; 2010 Jan; 162(1):91-101. PubMed ID: 19785596 [Abstract] [Full Text] [Related]
19. Mast cells in systemic and cutaneous lupus erythematosus. Kaczmarczyk-Sekuła K, Dyduch G, Kostański M, Wielowieyska-Szybińska D, Szpor J, Białas M, Okoń K. Pol J Pathol; 2015 Dec; 66(4):397-402. PubMed ID: 27003772 [Abstract] [Full Text] [Related]
20. The phenotypic profile of dermatomyositis and lupus erythematosus: a comparative analysis. Magro CM, Segal JP, Crowson AN, Chadwick P. J Cutan Pathol; 2010 Jun; 37(6):659-71. PubMed ID: 19891658 [Abstract] [Full Text] [Related] Page: [Next] [New Search]